Cannabidiol as a therapeutic modality for covid-19
US-2023338396-A1 · Oct 26, 2023 · US
This page is not indexed by search engines while we improve data quality.
Patent family 78525020
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 78525020 |
| Family type | — |
| Earliest priority | May 14, 2020 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US2023338396A1 — Cannabidiol as a therapeutic modality for covid-19 |
Representative publication
Best representative member for this family based on priority and filing country.
US2023338396A1 — Cannabidiol as a therapeutic modality for covid-19 (published Oct 26, 2023)
Member publications
Related publications in this family.